Compositions and Methods for Treating Pulmonary Hypertension
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 10 of these applications claim priority to application 62/510,403, filed May 24, 2017. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 10,695,405 | Compositions and Methods for Treating Pulmonary Hypertension In force · Medium confidence UsedRemaining | Acceleron Pharma Inc. | In force | Medium confidence | ||
| US 10,722,558 | Compositions and Methods for Treating Pulmonary Hypertension In force · Medium confidence | Acceleron Pharma Inc. | In force | Medium confidence | ||
| US 10,946,067 | Compositions and Methods for Treating Pulmonary Hypertension In force · Medium confidence | Acceleron Pharma Inc. | In force | Medium confidence | ||
| US 10,973,880 | Compositions and Methods for Treating Pulmonary Hypertension In force · Medium confidence | Acceleron Pharma Inc. | In force | Medium confidence | ||
| US 11,065,303 | Compositions and Methods for Treating Pulmonary Hypertension In force · Medium confidence | Acceleron Pharma Inc. | In force | Medium confidence | ||
| US 11,219,666 | Compositions and Methods for Treating Pulmonary Hypertension In force · Medium confidence | Acceleron Pharma Inc. | In force | Medium confidence | ||
| US 11,318,188 | Compositions and Methods for Treating Pulmonary Hypertension In force · High confidence | Acceleron Pharma Inc. | In force | High confidence | ||
| US 11,497,794 | Compositions and Methods for Treating Pulmonary Hypertension In force · High confidence | Acceleron Pharma Inc. | In force | High confidence | ||
| US 11,622,992 | Compositions and Methods for Treating Pulmonary Hypertension In force · Medium confidence | Acceleron Pharma Inc. | In force | Medium confidence | ||
| US 12,343,378 | Compositions and Methods for Treating Pulmonary Hypertension In force · Medium confidence | Acceleron Pharma Inc. | In force | Medium confidence | ||
| 2 more records in this group · Pro | ||||||
10 of 12 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 12.
10 of these are in force and held by Acceleron Pharma Inc..
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.